Investigating the effect of diet based on the global diet quality score in hemodialysis

Investigating the effect of Global Diet Quality Score (GDQS) compared to the control diet (diet for hemodialysis patients) on the levels of creatinine (Cr), blood urea nitrogen (BUN) and serum electrolytes in individuals with chronic kidney disease under hemodialysis: A randomized clinical trial study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210427051098N5

Enrollment

Registered

2023-12-11

Start date

2023-12-22

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

individuals with chronic kidney disease under hemodialysis. Hypotension of hemodialysis

Interventions

Intervention 1: Intervention group: In the GDQS-based diet group, people undergoing hemodialysis treatment will receive GDQS diet training for 12 weeks (one training session per week) and each session

But if the body mass index is more than 25, the adjusted weight of people according to the body mass index of 25 is used to calculate energy. In the control group, the standard diet of hemodialysis pa

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Individuals under hemodialysis (at least 2 times a week) for at least 1 months or more Completion of informed consent

Exclusion criteria

Exclusion criteria: History of cancer Suffering from hepatitis Suffering from liver cancer Taking medications for liver disease Having a specific perception or psychological disorder Immunodeficiency AIDS Suffering from a severe inflammatory disease Pregnancy Lactation

Design outcomes

Primary

Measure	Time frame
Creatinine. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Blood urea nitrogen (BUN). Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Serum Albumin. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Alkaline phosphatase. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Parathormone. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Total bilirubin. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Direct bilirubin. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Sodium. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Potassium. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Phosphorus. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Calcium. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Fasting Blood Glucose. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Total cholesterol. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Triglyceride. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Depression. Timepoint: Before the intervention, 12 weeks after the intervention. Meth	—

Measure

Time frame

Creatinine. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Blood urea nitrogen (BUN). Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Serum Albumin. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Alkaline phosphatase. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Parathormone. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Total bilirubin. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Direct bilirubin. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Sodium. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Potassium. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Phosphorus. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Calcium. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Fasting Blood Glucose. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Total cholesterol. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Triglyceride. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Pars Azmoun biochemical kit.;Depression. Timepoint: Before the intervention, 12 weeks after the intervention. Meth

—

Secondary

Measure	Time frame
Weight. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Weighting scale.;Body Mass Index (BMI). Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Body composition analyzer.;Waist circumference. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Tape measure.;Hips circumference. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Tape measure.;Fat mass. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Body composition analyzer.;Fat free mass. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Body composition analyzer.;Blood pressure. Timepoint: Before the intervention, 12 weeks after the interventio. Method of measurement: Measurement of systolic and diastolic blood pressure (mmHg).	—

Measure

Time frame

Weight. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Weighting scale.;Body Mass Index (BMI). Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Body composition analyzer.;Waist circumference. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Tape measure.;Hips circumference. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Tape measure.;Fat mass. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Body composition analyzer.;Fat free mass. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Body composition analyzer.;Blood pressure. Timepoint: Before the intervention, 12 weeks after the interventio. Method of measurement: Measurement of systolic and diastolic blood pressure (mmHg).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSara Bagherpour

Yazd University of Medical Sciences

sarabagherpour1376@gmail.com+98 35 3149 2228

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026